Hi Wallup,
I think CITI have a $3.39 price target thats 12 months back from when Aventis come to the party .Mine $5 is 12 months on from FDA approval.
Sorry if i failed to say that or posted differently.
Point is the good biotechs soon separate from the pretenders.
QRX on the rise with some numbers on the buy side.
Regards,